Live Quote · NYSEQGENHealthcare · Medical - Diagnostics & Research

Qiagen N.V.

$40.10▲ 2.48%(+$0.97)

TickerSpark Score

80/100

▌ Strong

87

Valuation

85

Profitability

80

Growth

100

Health

50

Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QGEN research report →

52-Week Range30% of range

Low

$32.53

Current

$40.10

High

$57.82

Company Overviewwww.qiagen.com

About the company

Qiagen N. V. provides sample to insight solutions that transform biological samples into molecular insights worldwide.

CEO: Thierry Bernard
IPO: 1996
Employees: 5,736
HQ: Venlo, LI, NL

Price Chart

-17.56% · this period

Valuation

Market Cap: $8.27B
P/E: 21.22
P/S: 3.94
P/B: 2.49
EV/EBITDA: 11.92
Div Yield: 6.33%

Profitability

Gross Margin: 61.58%
Op Margin: 24.85%
Net Margin: 19.16%
ROE: 11.28%
ROIC: 8.66%

Growth & Income

Revenue: $2.09B · 5.65%
Net Income: $424.88M · 408.28%
EPS: $2.04 · 423.08%
Op Income: $520.31M
FCF YoY: -10.49%

Performance & Tape

52W High: $57.82
52W Low: $32.53
50D MA: $36.15
200D MA: $43.62
Beta: 0.64
Avg Volume: 2.27M

Get TickerSpark's AI analysis on QGEN

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Coverage · QGEN